From Name

From Email

To Name

To Email

Message

Alzheimer's discoveries show new promise for drug development, expert says

from McKnight's Long-Term Care News

Alzheimer's discoveries show new promise for drug development, expert says McKnight's Long-Term Care News The discovery of new biomarkers other than amyloid or tau is an optimistic sign for Alzheimer's drug development, according to an expert on clinical research in the field. Biomarkers are used as a measurement of disease and have the potential to better define patient populations for Alzheimer's clinical trials. READ MORE

more